阿普唑仑:修订间差异
外观
删除的内容 添加的内容
无编辑摘要 |
无编辑摘要 |
||
第2行: | 第2行: | ||
{{weasel|time=2018-09-20T08:57:05+00:00}} |
{{weasel|time=2018-09-20T08:57:05+00:00}} |
||
{{Expand language|en}} |
{{Expand language|en}} |
||
{{copyedit|time=2017-03-03T16:12:01+00:00}} |
|||
}} |
}} |
||
{{CJK-New-Char|44EC|ver=A}} |
{{CJK-New-Char|44EC|ver=A}} |
||
第64行: | 第63行: | ||
| StdInChIKey = VREFGVBLTWBCJP-UHFFFAOYSA-N |
| StdInChIKey = VREFGVBLTWBCJP-UHFFFAOYSA-N |
||
}} |
}} |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
[[File:Alprazolam sales in China.jpg|thumb|在中国大陆销售的阿普唑仑片]] |
[[File:Alprazolam sales in China.jpg|thumb|在中国大陆销售的阿普唑仑片]] |
||
== |
==副作用== |
||
[[File:Xanax 2 mg.jpg|thumb| |
[[File:Xanax 2 mg.jpg|thumb|Xanax(阿普唑崙)2毫克三片連狀錠劑]] |
||
可能的副作用包括: |
可能的副作用包括: |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
*[[失控 (心理學)|失控]](Disinhibition)<ref name="Michel L, Lang JP 2003 479–85">{{Cite journal | last1 = Michel | first1 = L. | last2 = Lang | first2 = J. P. | trans_title = Benzodiazepines and Forensic Aspects | language = fr | journal = Encephale | year = 2003 | volume = 29 | issue = 6 | pages = 479–485 | pmid = 15029082 | url = http://www.masson.fr/masson/MDOI-ENC-12-2003-29-6-0013-7006-101019-ART2 | title = Benzodiazépines et passage à l'acte criminel | deadurl = no | accessdate = 9 April 2013}}</ref> |
*[[失控 (心理學)|失控]](Disinhibition)<ref name="Michel L, Lang JP 2003 479–85">{{Cite journal | last1 = Michel | first1 = L. | last2 = Lang | first2 = J. P. | trans_title = Benzodiazepines and Forensic Aspects | language = fr | journal = Encephale | year = 2003 | volume = 29 | issue = 6 | pages = 479–485 | pmid = 15029082 | url = http://www.masson.fr/masson/MDOI-ENC-12-2003-29-6-0013-7006-101019-ART2 | title = Benzodiazépines et passage à l'acte criminel | deadurl = no | accessdate = 9 April 2013}}</ref> |
||
*[[性冲动|性慾]]變化<ref>{{cite web | url = http://www.medicinenet.com/alprazolam-oral/article.htm | title = ALPRAZOLAM – ORAL (Xanax) side effects, medical uses, and drug interactions | accessdate = 2 August 2007 | publisher = Medicinenet.com | archiveurl = https://web.archive.org/web/20070825072108/http://www.medicinenet.com/alprazolam-oral/article.htm | archivedate = 25 August 2007 | deadurl = no}}</ref> |
*[[性冲动|性慾]]變化<ref>{{cite web | url = http://www.medicinenet.com/alprazolam-oral/article.htm | title = ALPRAZOLAM – ORAL (Xanax) side effects, medical uses, and drug interactions | accessdate = 2 August 2007 | publisher = Medicinenet.com | archiveurl = https://web.archive.org/web/20070825072108/http://www.medicinenet.com/alprazolam-oral/article.htm | archivedate = 25 August 2007 | deadurl = no}}</ref> |
||
第91行: | 第85行: | ||
*[[睡意]](Somnolence)、[[暈眩]](dizziness)、[[頭重腳輕]](lightheadedness)、[[疲倦]]、不穩定及受損的[[运动协调]]、[[眩暈 (醫學)|眩暈]](vertigo)<ref name=drftb>{{Cite journal | last = Rawson | first = N. S. | last2 = Rawson | first2 = M. J. | title = Acute Adverse Event Signalling Scheme Using the Saskatchewan Administrative Health Care Utilization Datafiles: Results for Two Benzodiazepines | journal = Canadian Journal of Clinical Pharmacology | year = 1999 | volume = 6 | issue = 3 | pages = 159–166 | pmid = 10495368}}</ref><ref name="acmirttoadom">{{cite web | url = http://www.medicinenet.com/alprazolam/article.htm | title = Alprazolam – Complete Medical Information Regarding This Treatment of Anxiety Disorders | publisher = MedicineNet | website = Medicinenet.com | accessdate = 2 August 2007}}</ref> |
*[[睡意]](Somnolence)、[[暈眩]](dizziness)、[[頭重腳輕]](lightheadedness)、[[疲倦]]、不穩定及受損的[[运动协调]]、[[眩暈 (醫學)|眩暈]](vertigo)<ref name=drftb>{{Cite journal | last = Rawson | first = N. S. | last2 = Rawson | first2 = M. J. | title = Acute Adverse Event Signalling Scheme Using the Saskatchewan Administrative Health Care Utilization Datafiles: Results for Two Benzodiazepines | journal = Canadian Journal of Clinical Pharmacology | year = 1999 | volume = 6 | issue = 3 | pages = 159–166 | pmid = 10495368}}</ref><ref name="acmirttoadom">{{cite web | url = http://www.medicinenet.com/alprazolam/article.htm | title = Alprazolam – Complete Medical Information Regarding This Treatment of Anxiety Disorders | publisher = MedicineNet | website = Medicinenet.com | accessdate = 2 August 2007}}</ref> |
||
===異常反應=== |
=== 異常反應 === |
||
[[File:Side effects of alprazolam.svg|thumb|阿普唑崙的[[副作用]].]] |
[[File:Side effects of alprazolam.svg|thumb|阿普唑崙的[[副作用]].]] |
||
使用阿普唑仑有可能會發生下面的異常反應: |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
*[[侵略 (社會科學)|侵略]]<ref>{{Cite journal | last1 = Rapaport | first1 = M. | last2 = Braff | first2 = D. L. | title = Alprazolam and Hostility | journal = American Journal of Psychiatry | year = 1985 | volume = 142 | issue = 1 | page = 146 | pmid = 2857070}}</ref> |
*[[侵略 (社會科學)|侵略]]<ref>{{Cite journal | last1 = Rapaport | first1 = M. | last2 = Braff | first2 = D. L. | title = Alprazolam and Hostility | journal = American Journal of Psychiatry | year = 1985 | volume = 142 | issue = 1 | page = 146 | pmid = 2857070}}</ref> |
||
*[[憤怒 (情感)|憤怒]] |
*[[憤怒 (情感)|憤怒]]、敵意<ref name="Michel L, Lang JP 2003 479–85" /> |
||
*[[震顫]] |
*[[震顫]](Fasciculations)及[[手震]]<ref>{{Cite journal | last1 = Béchir | first1 = M. | last2 = Schwegler | first2 = K. | last3 = Chenevard | first3 = R. | last4 = Binggeli | first4 = C. | last5 = Caduff | first5 = C. | last6 = Büchi | first6 = S. | last7 = Buddeberg | first7 = C. | last8 = Lüscher | first8 = T. F. | last9 = Noll | first9 = G. | displayauthors = 6 | title = Anxiolytic Therapy with Alprazolam Increases Muscle Sympathetic Activity in Patients with Panic Disorders | journal = Autonomic Neuroscience | year = 2007 | volume = 134 | issue = 1–2 | pages = 69–73 | pmid = 17363337 | doi = 10.1016/j.autneu.2007.01.007}}</ref> |
||
*[[瘋狂]] |
*[[瘋狂]](Mania)、[[躁動]](Psychomotor agitation)、[[肺熱]](hyperactivity)、慌張(restlessness)<ref>{{Cite journal | last1 = Arana | first1 = G. W. | last2 = Pearlman | first2 = C. | last3 = Shader | first3 = R. I. | title = Alprazolam-Induced Mania: Two Clinical Cases | journal = American Journal of Psychiatry | year = 1985 | volume = 142 | issue = 3 | pages = 368–369 | pmid = 2857534}}</ref><ref>{{Cite journal | last1 = Strahan | first1 = A. | last2 = Rosenthal | first2 = J. | last3 = Kaswan | first3 = M. | last4 = Winston | first4 = A. | title = Three Case Reports of Acute Paroxysmal Excitement Associated with Alprazolam Treatment | journal = American Journal of Psychiatry | volume = 142 | issue = 7 | pages = 859–861 | year = 1985 | pmid = 2861755}}</ref><ref>{{Cite journal | last1 = Reddy | first1 = J. | last2 = Khanna | first2 = S. | last3 = Anand | first3 = U. | last4 = Banerjee | first4 = A. | title = Alprazolam-Induced Hypomania | journal = Australia and New Zealand Journal of Psychiatry | year = 1996 | volume = 30 | issue = 4 | pages = 550–552 | pmid = 8887708 | doi = 10.3109/00048679609065031}}</ref> |
||
⚫ | |||
⚫ | 阿普唑崙的代謝主要是通過[[CYP3A4|CYP<sub>3</sub>A<sub>4</sub>]]進行 |
||
==化學程序== |
|||
⚫ | |||
⚫ | |||
==商標名稱== |
|||
⚫ | 阿普唑崙的代謝主要是通過[[CYP3A4|CYP<sub>3</sub>A<sub>4</sub>]]進行<ref name="Otani-2003">{{Cite journal | last1 = Otani | first1 = K. | title = Cytochrome P450 3A4 and Benzodiazepines | language = ja | journal = Seishin Shinkeigaku Zasshi | volume = 105 | issue = 5 | pages = 631–642 | year = 2003 | pmid = 12875231}}</ref>,結合[[CYP3A4|CYP<sub>3</sub>A<sub>4</sub>]]临床上,抑製劑諸如[[西咪替丁]]、[[紅黴素]]、[[氟西汀]]、[[氟伏沙明]]、[[伊曲康唑]]、[[酮康唑]]、[[奈法唑酮]](Nefazodone)、[[丙氧芬]](Propoxyphene)、[[利托那韋]](Ritonavir)等可以延緩阿普唑崙的[[肝清除率]],但是這可能導致阿普唑崙在人体内部的的過度積纍<ref>{{Cite journal | last1 = Dresser | first1 = G. K. | last2 = Spence | first2 = J. D. | last3 = Bailey | first3 = D. G. | title = Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition | journal = Clinical Pharmacokinetics | year = 2000 | volume = 38 | issue = 1 | pages = 41–57 | pmid = 10668858 | doi = 10.2165/00003088-200038010-00003}}</ref>,如此很有可能會導致其不良反應更加的惡化<ref name=cpoati>{{cite journal | last1 = Greenblatt | first1 = D. J. | last2 = Wright | first2 = C. E. | title = Clinical Pharmacokinetics of Alprazolam. Therapeutic Implications | journal = Clinical Pharmacokinetics | year = 1993 | volume = 24 | issue = 6 | pages = 453–471 | doi = 10.2165/00003088-199324060-00003 | pmid = 8513649}}</ref><ref>{{Cite journal | last1 = Wang | first1 = J. S. | last2 = Chase | first2 = C. L. | title = Pharmacokinetics and Drug Interactions of the Sedative Hypnotics | journal = Psychopharmacological Bulletin | year = 2003 | volume = 37 | issue = 1 | pages = 10–29 | pmid = 14561946 | doi = 10.1007/BF01990373 | url = http://www.medworksmedia.com/psychopharmbulletin/pdf/12/010-029_PB%20W03_Wang_final.pdf | archiveurl = https://web.archive.org/web/20070709230745/http://www.medworksmedia.com/psychopharmbulletin/pdf/12/010-029_PB%20W03_Wang_final.pdf | archivedate = 2007-07-09 | format = PDF}}</ref>。 |
||
* {{lang|en|Amprazo}}(柔安)<small>(淺粉紅色橢圓形)</small>錠劑0.5公絲,"中國化學製藥股份有限公司". Amprazo 0.5mg(Alprazolam) tablet。 |
|||
==參考資料== |
==參考資料== |
2019年2月19日 (二) 11:05的版本
臨床資料 | |
---|---|
商品名 | Xanax |
AHFS/Drugs.com | Monograph |
MedlinePlus | a684001 |
依賴性 | 高 |
给药途径 | 口服,舌下 |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
生物利用度 | 80–90% |
药物代谢 | 肝脏, 通过CYP3A4酶 |
生物半衰期 | 普释片: 11.2 小时,[1] 缓释片: 10.7–15.8 小时[2] |
排泄途徑 | 肾脏 |
识别信息 | |
| |
CAS号 | 28981-97-7 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.044.849 |
化学信息 | |
化学式 | C17H13ClN4 |
摩尔质量 | 308.765 |
3D模型(JSmol) | |
| |
|
阿普唑仑(Alprazolam)又名佳静安定,欧美部分国家商品名为赞安诺(Xanax)。长期服用会导致成瘾。此药在中国通常为0.4mg/片的片剂,临床一般用于抗焦虑和催眠。
与氯硝西泮的镇静作用不同,该药的药效镇静的同时又有一定改善情绪的作用,因而阿普唑仑多用于抑郁伴有失眠或焦虑的患者,而氯硝西泮多用于伴有兴奋、躁动的精神疾病患者。
副作用
可能的副作用包括:
- 失控(Disinhibition)[3]
- 性慾變化[4]
- 黄疸(非常罕見)[5]
- 幻觉(罕見)[6]
- 口乾(不頻繁)[7]
- 失調、鬆弛發音[8]
- 自殺意念(Suicidal ideation)(罕見)[9][10]
- 尿瀦留(不頻繁)[11]
- 疹、通氣不足(respiratory depression)、便秘[12][13]
- 顺行性遗忘症[14] 及注意集中等問題
- 睡意(Somnolence)、暈眩(dizziness)、頭重腳輕(lightheadedness)、疲倦、不穩定及受損的运动协调、眩暈(vertigo)[12][13]
異常反應
使用阿普唑仑有可能會發生下面的異常反應:
- 視覺變化
- 醉酒感
- 興奮
- 打电话、网络聊天
- 驾驶车辆
- 侵略[15]
- 憤怒、敵意[3]
- 震顫(Fasciculations)及手震[16]
- 瘋狂(Mania)、躁動(Psychomotor agitation)、肺熱(hyperactivity)、慌張(restlessness)[17][18][19]
食品和藥物相互作用
阿普唑崙的代謝主要是通過CYP3A4進行[20],結合CYP3A4临床上,抑製劑諸如西咪替丁、紅黴素、氟西汀、氟伏沙明、伊曲康唑、酮康唑、奈法唑酮(Nefazodone)、丙氧芬(Propoxyphene)、利托那韋(Ritonavir)等可以延緩阿普唑崙的肝清除率,但是這可能導致阿普唑崙在人体内部的的過度積纍[21],如此很有可能會導致其不良反應更加的惡化[22][23]。
參考資料
- ^ Xanax (Alprazolam) Clinical Pharmacology – Prescription Drugs and Medications. RxList. First DataBank. July 2008.
- ^ Xanax XR (Alprazolam) Clinical Pharmacology – Prescription Drugs and Medications. RxList. First DataBank. July 2008.
- ^ 3.0 3.1 Michel, L.; Lang, J. P. Benzodiazépines et passage à l'acte criminel [Benzodiazepines and Forensic Aspects]. Encephale. 2003, 29 (6): 479–485 [9 April 2013]. PMID 15029082 (法语).
- ^ ALPRAZOLAM – ORAL (Xanax) side effects, medical uses, and drug interactions. Medicinenet.com. [2 August 2007]. (原始内容存档于25 August 2007).
- ^ Noyes, R.; DuPont, R. L.; Pecknold, J. C.; Rifkin, A.; Rubin, R. T.; Swinson, R. P.; et al. Alprazolam in Panic Disorder and Agoraphobia: Results from a Multicenter Trial. II. Patient Acceptance, Side Effects, and Safety. Archives of General Psychiatry. 1988, 45 (5): 423–428. PMID 3358644. doi:10.1001/archpsyc.1988.01800290037005.
- ^ Complete Alprazolam Information. Drugs.com. [2 August 2007]. (原始内容存档于5 August 2007).
- ^ Elie, R.; Lamontagne, Y. Alprazolam and Diazepam in the Treatment of Generalized Anxiety. Journal of Clinical Psychopharmacology. 1984, 4 (3): 125–129. PMID 6145726. doi:10.1097/00004714-198406000-00002.
- ^ Cassano, G. B.; Toni, C.; Petracca, A.; Deltito, J.; Benkert, O.; Curtis, G.; et al. Adverse Effects Associated with the Short-term Treatment of Panic Disorder with Imipramine, Alprazolam or Placebo. European Neuropsychopharmacology. 1994, 4 (1): 47–53. PMID 8204996. doi:10.1016/0924-977X(94)90314-X.
- ^ Hori, A. Pharmacotherapy for Personality Disorders. Psychiatry and Clinical Neurosciences. 1998, 52 (1): 13–19. PMID 9682928. doi:10.1111/j.1440-1819.1998.tb00967.x.
- ^ Kravitz, H. M.; Fawcett, J.; Newman, A. J. Alprazolam and Depression: A Review of Risks and Benefits. Journal of Clinical Psychiatry. 1993, 54 (Supplement): 78–84; discussion 85. PMID 8262892.
- ^ Alprazolam Side Effects, Interactions and Information. Drugs.com. [2 August 2007]. (原始内容存档于19 August 2007).
- ^ 12.0 12.1 Rawson, N. S.; Rawson, M. J. Acute Adverse Event Signalling Scheme Using the Saskatchewan Administrative Health Care Utilization Datafiles: Results for Two Benzodiazepines. Canadian Journal of Clinical Pharmacology. 1999, 6 (3): 159–166. PMID 10495368.
- ^ 13.0 13.1 Alprazolam – Complete Medical Information Regarding This Treatment of Anxiety Disorders. Medicinenet.com. MedicineNet. [2 August 2007].
- ^ Barbee, J. G. Memory, Benzodiazepines, and Anxiety: Integration of Theoretical and Clinical Perspectives. The Journal of Clinical Psychiatry. 1993, 54 (Suppl): 86–97; discussion 98–101. PMID 8262893.
- ^ Rapaport, M.; Braff, D. L. Alprazolam and Hostility. American Journal of Psychiatry. 1985, 142 (1): 146. PMID 2857070.
- ^ Béchir, M.; Schwegler, K.; Chenevard, R.; Binggeli, C.; Caduff, C.; Büchi, S.; et al. Anxiolytic Therapy with Alprazolam Increases Muscle Sympathetic Activity in Patients with Panic Disorders. Autonomic Neuroscience. 2007, 134 (1–2): 69–73. PMID 17363337. doi:10.1016/j.autneu.2007.01.007.
- ^ Arana, G. W.; Pearlman, C.; Shader, R. I. Alprazolam-Induced Mania: Two Clinical Cases. American Journal of Psychiatry. 1985, 142 (3): 368–369. PMID 2857534.
- ^ Strahan, A.; Rosenthal, J.; Kaswan, M.; Winston, A. Three Case Reports of Acute Paroxysmal Excitement Associated with Alprazolam Treatment. American Journal of Psychiatry. 1985, 142 (7): 859–861. PMID 2861755.
- ^ Reddy, J.; Khanna, S.; Anand, U.; Banerjee, A. Alprazolam-Induced Hypomania. Australia and New Zealand Journal of Psychiatry. 1996, 30 (4): 550–552. PMID 8887708. doi:10.3109/00048679609065031.
- ^ Otani, K. Cytochrome P450 3A4 and Benzodiazepines. Seishin Shinkeigaku Zasshi. 2003, 105 (5): 631–642. PMID 12875231 (日语).
- ^ Dresser, G. K.; Spence, J. D.; Bailey, D. G. Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition. Clinical Pharmacokinetics. 2000, 38 (1): 41–57. PMID 10668858. doi:10.2165/00003088-200038010-00003.
- ^ Greenblatt, D. J.; Wright, C. E. Clinical Pharmacokinetics of Alprazolam. Therapeutic Implications. Clinical Pharmacokinetics. 1993, 24 (6): 453–471. PMID 8513649. doi:10.2165/00003088-199324060-00003.
- ^ Wang, J. S.; Chase, C. L. Pharmacokinetics and Drug Interactions of the Sedative Hypnotics (PDF). Psychopharmacological Bulletin. 2003, 37 (1): 10–29. PMID 14561946. doi:10.1007/BF01990373. (原始内容 (PDF)存档于2007-07-09).